Skip to content
Screener

Wave Life Sciences WVE Interest Income

Interest Income at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$6.21M+18.1%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$20.23M-18.1%
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
$7.1M-13.7%
ALN
Alnylam PharmaceuticalsALNY
$28.14M+2.4%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$8.76M+23.3%
Prime Medicine logo
Prime MedicinePRME
$788K+6.1%

Other financials

Income statement

See full
Revenue$2.3M-73.9%
Operating income-$73.8M-39.9%
Net income-$69.4M-37.4%
EPS (diluted)-$0.34-9.7%

Balance sheet

See full
Cash & equivalents$368.0M+76.5%
Total debt$43.6M+101%
Total equity$453.5M+226%
Total assets$558.3M+121%

Cash flow

See full
Operating cash flow-$53.6M-16.5%
CapEx$884.0K+189%
Free cash flow-$54.5M-17.6%

Valuation

See full
Market cap$1.2B-7.3%
Enterprise value$871.66M-21.0%
P/S20.5×-16.6×

Profitability

See full
Operating margin-75.7%-33.6pp
Net margin-66.5%-29.9pp
FCF margin-27.2%-12.6pp

Returns & leverage

See full
Return on equity-68.3%
Debt / equity0.1×-0.1×
Current ratio10×+7.4×

Where this comes from

Reported directly by Wave Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The source filing: Wave Life Sciences’s 10-Q, filed July 30, 2026.

Filed
Jul 30, 2026, 7:50 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-324949
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Total operating expenses76,07461,458145,617120,437
Loss from operations(73,802)(52,759)(105,099)(102,563)
Other income, net:
Interest income4,7222,37210,0135,247
Other expense(275)(82)(356)(31)
Total other income, net4,4472,2909,6575,216
Loss before income taxes(69,355)(50,469)(95,442)(97,347)
Income tax benefit

Item 1. Financial Statements

FAQ

What is Wave Life Sciences's interest income?
Wave Life Sciences (WVE) reported interest income of $4.72M in Q2 2026.
How has Wave Life Sciences's interest income changed year-over-year?
Wave Life Sciences's interest income increased by 99.1% year-over-year, from $2.37M to $4.72M.
What is the long-term trend for Wave Life Sciences's interest income?
Over 4 years (2021 to 2025), Wave Life Sciences's interest income has grown at a 332.3% compound annual growth rate (CAGR), from $30K to $10.48M.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.

Ask your AI about Wave Life Sciences's interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude